Diagram of TENS electrode placement and nerve stimulation pathway for pain modulation

Deep Dive 11 min read · Updated 4 June 2026

How Does TENS Work? The Science of Electrical Pain Relief

TENS (transcutaneous electrical nerve stimulation) delivers low-level electrical current through electrode pads on the skin to modulate pain perception. The mechanism is well-understood and grounded in established neuroscience — two complementary pathways explain most of the observed effects. Understanding how TENS works helps users select the right stimulation parameters, position electrodes correctly, and have realistic expectations about what the technology does and does not do.

Updated 4 June 2026 11 min read 5 sources cited

Key Concepts

Transcutaneous electrical nerve stimulation (TENS): Delivery of electrical current through surface electrode pads to stimulate peripheral nerves without penetrating the skin.
Gate control theory: Melzack and Wall's 1965 model proposing that non-painful sensory input can inhibit pain signals at the spinal cord level — the mechanism underlying high-frequency TENS.
A-beta fibres: Large-diameter myelinated sensory nerve fibres that conduct touch and vibration. Selectively activated by high-frequency TENS to close the pain gate.
C fibres: Small-diameter unmyelinated fibres that conduct slow pain signals. Their input is inhibited when A-beta fibre activity is high — the basis of gate control pain relief.
Endogenous opioids: The body's own pain-modulating peptides (endorphins, enkephalins, dynorphins) released by low-frequency burst TENS.
Pulse width: Duration of each electrical pulse in microseconds. Wider pulses affect deeper or more muscle tissue; narrower pulses are selective for sensory nerve stimulation.
Frequency: Number of electrical pulses per second (Hz). High-frequency TENS (80–150 Hz) activates gate control; low-frequency burst TENS (2–4 Hz) activates opioid pathways.

Sources & Methodology

This article draws on the foundational pain neuroscience literature (Melzack & Wall, 1965), clinical TENS research spanning three decades, and systematic reviews including the 2019 Cochrane overview of TENS for chronic pain (Gibson et al.). GreatHealthGear does not conduct clinical research. All content reflects the published evidence consensus as of the stated publication date.

The Two Mechanisms of TENS

TENS does not work through a single process. Two distinct neurophysiological mechanisms operate depending on the stimulation parameters — particularly frequency and pulse width. Understanding them explains why different TENS settings are recommended for different pain types.

Mechanism 1: Gate Control (High-Frequency TENS)

The gate control theory of pain, proposed by Melzack and Wall in 1965, remains the most influential model in pain neuroscience. Its key proposition: pain signals can be inhibited at the spinal cord before they reach the brain, and non-painful sensory input can close that gate.

The mechanism in TENS:

High-frequency TENS (80–150 Hz) selectively activates large-diameter A-beta sensory nerve fibres. These fibres normally carry touch and vibration information — the sensation of rubbing an injury intuitively reducing pain is the same mechanism.
Activated A-beta fibres synapse on inhibitory interneurons in the dorsal horn of the spinal cord (substantia gelatinosa).
These interneurons inhibit the transmission cells (T-cells) that relay pain signals toward the brain via the spinothalamic tract.
Pain signal transmission is reduced — the gate is closed.

This is why high-frequency TENS produces a tingling or buzzing sensation without muscle contraction: A-beta fibres are activated at intensities below the motor nerve threshold.

Sluka & Walsh (2003) in the *Journal of Pain* confirmed that high-frequency TENS at 100 Hz selectively activates A-beta fibres and produces dorsal horn inhibition of C fibre input — providing direct electrophysiological evidence for gate control as the operative mechanism.

Mechanism 2: Endogenous Opioid Release (Low-Frequency Burst TENS)

Low-frequency burst TENS operates through a different pathway:

Low-frequency stimulation (2–4 Hz), typically applied as brief bursts rather than continuous pulses, activates small-diameter A-delta fibres.
This stimulation pattern triggers the release of endogenous opioid peptides — predominantly enkephalins in the spinal cord and beta-endorphins in the brainstem.
These peptides bind to opioid receptors in pain processing pathways, reducing pain signal transmission.
The analgesic effect is slower to onset than gate control TENS but longer-lasting after the session ends.

Evidence for the opioid mechanism: pain relief from low-frequency TENS is partially reversed by naloxone (an opioid antagonist), confirming that endogenous opioid activity is responsible for a portion of the effect.

Multiple studies cited in Vance et al. (2014) in *Pain Management* confirm the naloxone-reversibility of low-frequency TENS analgesia, with effects more pronounced for burst than continuous low-frequency stimulation.

TENS Parameters and Their Effects

Understanding the main parameters explains why different TENS modes feel and work differently:

Frequency (Hz)

High frequency (80–150 Hz): Activates gate control. Produces quick-onset tingling sensation. Provides pain relief during stimulation, with shorter carry-over effects.
Low frequency (2–4 Hz): Activates opioid pathways. Produces visible muscle twitches at motor threshold. Slower onset, longer carry-over pain relief.
Modulated frequency: Alternates between frequencies within a session to prevent accommodation and target both pathways.

Pulse Width (microseconds)

Wider pulses (200–300 μs) are required to stimulate deeper or motor nerves. Narrower pulses (50–100 μs) selectively stimulate superficial sensory nerves with less motor nerve co-activation. Most OTC TENS devices operate in the 50–300 μs range; the optimal setting varies by electrode placement and pain site depth.

Intensity (mA)

The most critical variable in clinical outcomes. Research consistently shows that sub-threshold intensities produce minimal pain relief. Effective TENS requires intensity high enough to produce a clear, strong (but comfortable) sensory response. Users who report TENS “does not work” are frequently running it at too low an intensity.

Turn the intensity up until you can clearly feel the TENS sensation, then a little further until it is strong but not uncomfortable. The most common TENS error is setting intensity too low — a subtle tingle rarely achieves meaningful gate control activation.

Electrode Placement: Why It Matters

The TENS current flows between the two electrodes. Pain relief occurs most effectively when:

Electrodes are placed around or near the pain site: The A-beta fibre activation needs to occur in the same dermatome or spinal segment as the pain for gate control to be effective.
Pain site is within the current path: Electrode placement remote from the pain site (the approach used for trigger points in acupuncture TENS) has less strong evidence for standard pain management use.
Electrode size matches the target area: Larger electrodes distribute current over a wider area; smaller electrodes concentrate it at a smaller site.

What TENS Does Not Do

Understanding the mechanism clarifies the limits:

TENS does not treat the underlying cause of pain. It modulates the perception of pain without affecting the structural, inflammatory, or neurological cause. A herniated disc, nerve root compression, arthritic joint degeneration, or fracture is unchanged by TENS.

TENS does not provide permanent pain relief. Its effects are symptomatic and time-limited. Pain typically returns when stimulation stops (especially for gate control TENS); carry-over effects vary.

TENS does not replace medical assessment. Unexplained pain, pain following trauma, pain with neurological features, or pain that does not respond to conservative management requires medical evaluation.

The Evidence Base for TENS

The 2019 Cochrane overview of reviews (Gibson et al.) examined 13 Cochrane Reviews of TENS across different conditions. Their summary: moderate evidence supports TENS over sham TENS for reducing pain intensity in chronic musculoskeletal pain, with effect sizes ranging from small to moderate. Evidence is strongest for chronic lower back pain and fibromyalgia; more limited for neuropathic presentations.

This places TENS in the category of interventions with a real but modest evidence base — useful as a component of pain management, not a comprehensive solution.

TENS is contraindicated in specific circumstances: pacemaker or implanted cardiac device; pregnancy (avoid abdominal and pelvic placement); active malignancy over the treatment site; epilepsy; impaired sensation at the treatment site (as you cannot detect excessive intensity). Always consult a healthcare professional before use if any contraindication may apply.

Frequently Asked Questions

Does TENS actually reduce pain or just distract from it?

Both mechanisms operate but are genuinely distinct. High-frequency TENS activates A-beta sensory fibres that inhibit pain signal transmission in the dorsal horn of the spinal cord — this is a physical interruption of pain signalling, not distraction. Low-frequency burst TENS triggers endogenous opioid release with measurable effects on naloxone-reversible pain reduction. The research supports these as real neurophysiological effects, not placebo distraction.

Why does TENS stop working after extended use?

Two forms of accommodation occur with repeated TENS: peripheral accommodation (reduced A-beta fibre response to continuous stimulation) and central accommodation (reduced dorsal horn inhibition over time). The solutions are: (1) using modulated TENS modes that vary frequency and pulse width to prevent accommodation; (2) alternating between high-frequency gate control TENS and low-frequency burst TENS across sessions; (3) taking breaks between sessions rather than running TENS continuously.

What is the difference between TENS and interferential current (IFC)?

TENS applies low-frequency current (1–150 Hz) directly to the skin. IFC uses two medium-frequency currents (typically 4,000 Hz) that cross within tissue, producing a beat frequency at depth. The medium-frequency carrier in IFC reduces skin impedance and allows the therapeutic signal to penetrate deeper tissue. IFC requires a prescription device (Zynex NexWave) in the US — it is not available OTC.

Can TENS work for pain that has no obvious physical cause?

TENS modulates pain perception at the level of the nervous system, independent of the underlying pain source. It can provide symptomatic relief for central sensitisation, chronic pain states, and functional pain conditions as well as structural pathology. The scientific understanding of TENS as a neural modulation tool — rather than a treatment for specific tissue damage — is why it has broader applicability than its mechanism might initially suggest. Consult a healthcare professional for pain without an identified cause before self-directing TENS.

References

Melzack, R., & Wall, P.D. (1965). Pain mechanisms: a new theory . Science, 150(3699), 971–979.
Johnson, M.I., Mulvey, M.R., & Bagnall, A.M. (2015). Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults . Cochrane Database of Systematic Reviews, Issue 8.
Gibson, W., Wand, B.M., Meads, C., Catley, M.J., & O'Connell, N.E. (2019). Transcutaneous electrical nerve stimulation (TENS) for chronic pain — an overview of Cochrane Reviews . Cochrane Database of Systematic Reviews, Issue 4.
Sluka, K.A., & Walsh, D. (2003). Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness . Journal of Pain, 4(3), 109–121.
Vance, C.G., Dailey, D.L., Rakel, B.A., & Sluka, K.A. (2014). Using TENS for pain control: the state of the evidence . Pain Management, 4(3), 197–209.